Crown Aesthetics announced the strategic acquisition of assets and technology from Healeon LLC, a subsidiary of Bimini Health Tech in the aesthetics PRP space. With decades of excellence, Bimini Health Tech is an international leader with products utilized in over 1.5 million procedures worldwide in regenerative therapies, and the aesthetic and reconstructive surgery markets. Bimini paved the way in developing, acquiring, and commercializing PRP products that provide premium solutions for patients and physicians.
The acquisition of these assets further strengthens the leadership position of Crown's ProGen PRP Eclipse brand, the first PRP brand to qualify and quantify the existence of autologous exosomes in its PRP, provides timely access for new product developments in the market, and ensures continual access to the highest quality PRP devices in the market. The business synergy also gives Crown the opportunity to expand geographic reach and continue to diversify production capabilities, further enriching lives across the globe. "The acquisition of these assets advances Crown's position as a leading provider of PRP solutions in the US and allow us to expand our PRP footprint globally," says Jeff Bedard, CEO, Crown Laboratories. "As our business evolves, our customers will have access to a comprehensive portfolio of innovative solutions to address their patients' unique needs, and delivering groundbreaking solutions backed by research and proven performance."